產(chǎn)品詳情
簡單介紹：
Anti-beta-Amyloid (1-40)抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-beta-Amyloid (1-40)抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Mouse Anti-beta-Amyloid (1-40)
Cat. Number:
Anti-beta-Amyloid (1-40)抗體KL-0106M
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The cerebral and vascular Anti-beta-Amyloid (1-40)抗體plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid antibodies and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.Anti-beta-Amyloid (1-40)抗體
Also known as:
beta Amyloid(1-40); beta Amyloid 1-40; beta-Amyloid 1-40; Amyloid 1-40; P3(40); A4; AAA; ABETA; ABPP; AD1; Alzheimers Anti-beta-Amyloid (1-40)抗體Disease Amyloid Protein; Amyloid B; Amyloid Beta A4 Protein Precursor; Amyloid Beta; Amyloid of Aging and Alzheimer Disease; APP; APPI; B Amyloid; Beta APP; Cerebral Vascular Amyloid Peptide; CTFgamma; CVAP; PN II; PN2; PreA4; Protease nexin II; A beta; A4_HUMAN; Beta-amyloid protein 40.
Specificity:
●
Mouse Monoclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human beta-Amyloid (1-40).
●
Predicted Molecular Weight: 4.2kDa.
Storage:
Shipped at 4℃, Store Anti-beta-Amyloid (1-40)抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl003Mu01 載脂蛋白B(APOB)多克隆抗體 Polyclonal Antibody to Apolipoprotein B (APOB)
kl003Ra01 載脂蛋白B(APOB)多克隆抗體 Polyclonal Antibody to Apolipoprotein B (APOB)
kl704Hu01 載脂蛋白E(APOE)多克隆抗體 Polyclonal Antibody to Apolipoprotein E (APOE)
kl704Mu01 載脂蛋白E(APOE)多克隆抗體 Polyclonal Antibody to Apolipoprotein E (APOE)
kl704Ra01 載脂蛋白E(APOE)多克隆抗體 Polyclonal Antibody to Apolipoprotein E (APOE)
kl519Hu01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Mu01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Ra01 載脂蛋白A1(APOA1)多克隆抗體 Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl033Hu01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Ra01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl578Hu01 Pim-1原癌基因(PIM1)多克隆抗體 Polyclonal Antibody to Pim-1 Oncogene (PIM1)
kl578Mu01 Pim-1原癌基因(PIM1)多克隆抗體 Polyclonal Antibody to Pim-1 Oncogene (PIM1)
kl578Ra01 Pim-1原癌基因(PIM1)多克隆抗體 Polyclonal Antibody to Pim-1 Oncogene (PIM1)
kl305Hu01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl305Mu01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl305Ra01 甲狀腺結(jié)合球蛋白(TBG)多克隆抗體 Polyclonal Antibody to Thyroxine Binding Globulin (TBG)
kl702Hu01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl702Mu01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl702Ra01 硫氧化還原蛋白(Trx)多克隆抗體 Polyclonal Antibody to Thioredoxin (Trx)
kl084Mu01 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl084Ra01 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl036Hu01 轉(zhuǎn)鐵蛋白(TRF)多克隆抗體 Polyclonal Antibody to Transferrin (TRF)
kl036Mu01 轉(zhuǎn)鐵蛋白(TRF)多克隆抗體 Polyclonal Antibody to Transferrin (TRF)
